Table 6.6h

Persistency of Discharge Regimen by Follow-up Period, 1999 to 2003

Recipients with Pancreas Transplant Alone (PTA) Transplants

  Year of Transplant
1999 2000 2001 2002 2003
Discharge Regimen (w/ or w/o Steroid Use) CyA+MMF At Discharge (N) 3 4 6 4 2
At Discharge (%) 100.0% 100.0% 100.0% 100.0% 100.0%
6 Months PostTx (%) 33.3% 50.0% 16.7% 50.0% 100.0%
1 Year PostTx (%) 33.3% 50.0% 16.7% 50.0% 100.0%
2 Years PostTx (%) 33.3% 50.0% 0.0% 25.0% -
3 Years PostTx (%) 33.3% 50.0% 0.0% - -
CyA+Siro At Discharge (N) - 1 - 1 1
At Discharge (%) - 100.0% - 100.0% 100.0%
6 Months PostTx (%) - 0.0% - 100.0% 100.0%
1 Year PostTx (%) - 0.0% - 100.0% -
2 Years PostTx (%) - 0.0% - 100.0% -
3 Years PostTx (%) - 0.0% - - -
Siro+MMF At Discharge (N) 1 - 1 - 1
At Discharge (%) 100.0% - 100.0% - 100.0%
6 Months PostTx (%) 100.0% - 0.0% - 100.0%
1 Year PostTx (%) 0.0% - 0.0% - 100.0%
2 Years PostTx (%) 0.0% - 0.0% - -
3 Years PostTx (%) 0.0% - 0.0% - -
Tac+Aza At Discharge (N) - 2 1 1 -
At Discharge (%) - 100.0% 100.0% 100.0% -
6 Months PostTx (%) - 50.0% 100.0% 100.0% -
1 Year PostTx (%) - 50.0% 100.0% 0.0% -
2 Years PostTx (%) - 50.0% 100.0% 0.0% -
3 Years PostTx (%) - 50.0% 100.0% 0.0% -
Tac+MMF At Discharge (N) 73 74 81 84 62
At Discharge (%) 100.0% 100.0% 100.0% 100.0% 100.0%
6 Months PostTx (%) 75.0% 80.9% 77.3% 82.1% 87.0%
1 Year PostTx (%) 61.1% 71.0% 68.3% 67.7% 75.6%
2 Years PostTx (%) 50.5% 54.5% 59.1% 60.9% 75.6%
3 Years PostTx (%) 43.9% 43.9% 53.2% 60.9% -
Tac+Siro At Discharge (N) 2 7 11 15 18
At Discharge (%) 100.0% 100.0% 100.0% 100.0% 100.0%
6 Months PostTx (%) 100.0% 100.0% 54.5% 86.7% 66.7%
1 Year PostTx (%) 100.0% 100.0% 45.5% 80.0% 66.7%
2 Years PostTx (%) 50.0% 100.0% 36.4% 65.5% 44.4%
3 Years PostTx (%) 50.0% 100.0% 36.4% - -


Source: OPTN/SRTR Data as of May 2, 2005.

Regimen change is defined as being on different drug combination at follow-up comparing to discharge, or indication of conflicting regimen(CyA vs. Tac; MMF/MPA vs. Aza; Siro vs. Evero) during follow-up peroid, or graft failure/death. Addition or deletion of steroids is not considered a regimen change.Rates are calculated for the most common discharge regimens.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine; Siro: Sirolimus.

See Technical Notes for further details.